Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins

ObjectivesTo determine the accuracy of post-operative MR in predicting residual disease in women with positive margins, emphasizing the size thresholds at which residual disease can be confidently identified.MethodsThis IRB-approved HIPAA-compliant retrospective study included 175 patients with MR a...

Full description

Saved in:
Bibliographic Details
Main Authors: Krammer, Julia (Author) , Schönberg, Stefan (Author)
Format: Article (Journal)
Language:English
Published: 2017
In: European radiology
Year: 2017, Volume: 27, Issue: 11, Pages: 4812-4818
ISSN:1432-1084
DOI:10.1007/s00330-017-4823-y
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s00330-017-4823-y
Verlag, Volltext: http://link.springer.com/article/10.1007/s00330-017-4823-y
Get full text
Author Notes:Julia Krammer, Elissa R. Price, Maxine S. Jochelson, Elizabeth Watson, Melissa P. Murray, Stefan O. Schoenberg, Elizabeth A. Morris
Description
Summary:ObjectivesTo determine the accuracy of post-operative MR in predicting residual disease in women with positive margins, emphasizing the size thresholds at which residual disease can be confidently identified.MethodsThis IRB-approved HIPAA-compliant retrospective study included 175 patients with MR after positive margins following initial surgery for breast cancer. Two expert readers independently re-evaluated MR images for evidence of residual disease at the surgical cavity and multifocal/multicentric disease. All patients underwent definitive surgery and MR findings were correlated to histopathology.Results139/175 (79.4%) patients had residual disease at surgery. Average overall sensitivity, specificity, PPV and NPV for residual disease at the surgical cavity were 73%, 72%, 91% and 45%, respectively. The readers identified 42/45 (93%, reader 1) and 43/45 (95%, reader 2) patients with residual invasive disease at the cavity of ≥5 mm and 22/22 (100%, both readers) patients with disease ≥10 mm. Average sensitivity, specificity, PPV and NPV for unknown multifocal/multicentric disease were 90%, 96%, 93% and 86%, respectively.ConclusionsPost-operative breast MR can accurately depict ≥5-mm residual disease at the surgical cavity and unsuspected multifocal/multicentric disease. These findings have the potential to lead to more appropriate selection of second surgical procedures in women with positive margins. Key Points • Post-operative breast MRI accurately defines residual disease of ≥5 mm. • Surgical cavity sensitivities were high for both invasive carcinoma and DCIS. • Post-surgical changes and very small residual disease (<5 mm) may overlap. • Post-operative breast MRI may help planning an accurate re-resection.
Item Description:Published online: 31 May 2017
Gesehen am 27.06.2018
Physical Description:Online Resource
ISSN:1432-1084
DOI:10.1007/s00330-017-4823-y